Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CMS Takes Steps To Implement New Dx Payment System

This article was originally published in The Gray Sheet

Executive Summary

The Medicare agency issued its proposed rule to implement diagnostics provisions of the Protecting Access to Medicare Act, which would transform how lab tests are paid to a more market-based system beginning in 2017. Although laboratories support the law, an industry group says CMS would leave too many labs out from reporting market data, threatening reimbursement accuracy.


Related Content

Labs Get Extra Year To Adjust To Diagnostics Reimbursement Revamp
Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst